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CASE REPORT
18F-FDG-PET-CT imaging findings of recurrent intracranial
haemangiopericytoma with distant metastases
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ABSTRACT. A 42-year-old woman presented with local recurrence and distant lung and
liver metastases 7 years after resection of a primary intracranial haemangiopericytoma.
Whole-body 18F-fluoro-2-deoxy-D-glucose (FDG)-positron emission tomography (PET)-
CT scan showed no increased uptake in local recurrence or distant metastases except for
a focus of increased FDG uptake within a hepatic metastasis. The hypermetabolic area
correlated with an intratumoral hypoenhancing area on the CT scan. PET-CT scan may
be useful to allow further understanding of the tumour.
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Haemangiopericytoma is an uncommon tumour and
accounts for less than 1% of all intracranial tumours. It
caused much confusion because of its imaging simila-
rities to meningioma and its uncertain cellular origin. Its
rarity, non-specific imaging findings and lack of specific
tumour markers pose diagnostic difficulties.
We report a case of intracranial haemangiopericytoma
treated with surgical resection. Local recurrence and
distant metastases in the lung and liver occurred seven
years after complete resection of the primary intracra-
nial tumour. 18F-fluoro-2-deoxy-D-glucose (FDG)-posi-
tron emission tomography–computed tomography (PET-
CT)was performed for assessment of the extent of disease.
Case report
A 42-year-old woman presented with headache and
unsteady gait for one month in September 2001. CT and
MRI scans of the brain showed an 8 cm extra-axial
homogeneous enhancing mass in the left posterior
cranial fossa causing hydrocephalus. The initial diag-
nosis was left cerebellar tentorial meningioma. Angio-
gram showed hypervascular tumour and the tumour
was supplied mainly by the tentorial branch of the left
internal carotid artery and branches from the left
vertebral artery and external carotid artery. Pre-operative
embolisation with 150–250 mm polyvinyl alcohol particles
and n-butyl cyanoacrylate was performed to reduce intra-
operative bleeding.
Histology from an intra-operative frozen section and
the whole surgical specimen diagnosed haemangioper-
icytoma. Randomly orientated plump cells and a rich
network of reticulum fibres investing individual cells
were found in the tumour. Characteristic staghorn
vessels were identified. Immunohistochemistry staining
of the tumour cells were focally positive for CD34, and
the findings were compatible with meningeal haeman-
giopericytoma [1, 2]. After total resection of the
tumour, the patient received post-operative cranial
irradiation.
The patient underwent regular clinical follow-up.
There was no sign of tumour recurrence until seven
years after the operation, when she complained of a
palpable epigastric mass with dull pain. Tumour
markers including carcinoembryonic antigen (CEA)
and alpha-fetoprotein (AFP) were normal. Hepatitis B
surface antigen was negative. Whole-body 18F-FDG-PET-
CT was obtained for further evaluation. The CT part of
the examination was performed with administration of
intravenous contrast, including both arterial and portal
venous phases of the liver.
CT showed seven well-defined arterial-phase enhan-
cing lesions in both hepatic lobes with sizes ranging from
7 mm to 7 cm. All of themwere eumetabolic to the uptake
of the background liver parenchyma (maximal standar-
dised uptake value (SUVmax) of 2.5) of except for the
largest lesion in segment IVb. This lesion showed marked
heterogeneous enhancement on arterial and later phases,
with a 4 cm well-defined internal eccentric hypodense
area (Figure 1). On PET scan, a small focus of elevated
FDG uptake with SUVmax of 3.6 (Figure 2) was noted in
the hypoenhancing centre, which is better demonstrated
on the fused image (Figure 3).
In addition, there were numerous metastatic nodules
in both lungs with a maximal size of 1 cm. Local
recurrence was also detected along the dura of the left
tentorium cerebelli just beneath the craniotomy site
(Figure 4). The lung and intracranial lesions showed no
elevated FDG uptake.
Ultrasound-guided liver biopsy of the segment IVb
lesion showed histological proof of metastatic haeman-
giopericytoma. Chemotherapy was arranged for the
patient.
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Discussion
Intracranial haemangiopericytoma is a rare tumour
and it is difficult to make the correct pre-operative
diagnosis based on clinical and imaging findings. Even
on histological findings, there was much confusion about
the origin of this tumour in the past. It was previously
named ‘‘haemangiopericytic meningioma’’ because of its
similar imaging findings to meningioma. Until 2000,
the World Health Organization separated the tumour
from meningioma owing to its distinctive histological
features [3].
It is important to diagnose haemangiopericytoma as it
tends to have local recurrence and its malignant type
may lead to distant metastases. Complete surgical
resection and adjuvant radiotherapy play an important
role in the management of intracranial haemangioper-
icytoma [4]. However, complete resection may not be
possible owing to its high vascularity and proximity to
dural sinuses. Therefore, post-operative radiation ther-
apy remains routine treatment even when complete
resection is indicated during surgery. Because of the
tumour’s hypervascularity, neoadjuvant radiotherapy is
also advocated to reduce intra-operative complications
[5]. Distant metastasis tends to have an indolent growth.
Liver and bone are common sites of metastasis and rare
sites including the heart, pancreas and breast have been
reported [6–8]. In our case, recurrence and distant
metastases occurred 7 years after surgery.
Intracranial haemangiopericytoma shows very similar
features to meningioma on both CT and MRI. It presents
as a markedly enhancing extra-axial mass and could also
Figure 1. Axial contrast-enhanced CT image of the liver
shows an enhancing mass with an internal hypoenhancing
centre (arrow) in hepatic segment IVb. Subsequent biopsy of
the mass confirms metastatic haemangiopericytoma.
Figure 2. Axial 18F-fluoro-2-deoxy-D-glucose-positron emis-
sion tomography image of the abdomen shows similar tracer
uptake in the lesion to adjacent liver parenchyma, except for
a hypermetabolic focus (arrow) in the centre of the lesion.
Figure 3. Axial positron emission tomography–CT fused
image shows the hypermetabolic focus (arrow) is within
the hypoenhancing centre of the lesion.
Figure 4. Reformatted coronal contrast-enhanced CT image
of the brain shows an enhancing local recurrent tumour
(arrow) along the left tentorium cerebelli beneath the
craniotomy site.
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show dural attachment and bone erosion, as in menin-
phygioma [9]. On angiography, it also shows marked
vascularity similar to meningioma. Therefore, other
imaging modalities and diagnostic methods are sought
to increase the accuracy in reaching the diagnosis.
Previous PET studies on meningioma showed that the
glucose metabolic rates of meningioma correlated with
the tumour growth, and atypical meningioma had the
highest glucose utilisation rate [10]. However, high-
grade sacral meningioma metastasis showing only
moderate metabolic activity on FDG-PET images has
been reported [11]. Since haemangiopericytoma is even
rarer than meningioma, the current literature on its PET
findings is scarce. A previous case report found that
haemangiopericytoma showed increased uptake of 11C-
methionine and O-H2O but low uptake on
18F-FDG [12].
In our case, most of the recurrent haemangiopericytomas
showed avid enhancement on CT but low FDG uptake on
PET, indicative of low glucose utilisation. However, the
dominant recurrent lesion in the liver demonstrated an
area of hypoenhancement on CT that showed increased
FDG uptake on PET. This kind of tumour imaging feature
has not been reported previously. One case report on
hepatic metastasis from haemangiopericytoma reported a
central hypoenhancing area in the metastasis. However,
the hypoenhancing area was necrotic and hypometabolic,
whereas the enhancing portion of the metastasis was
hypermetabolic [13]. We believe it is important to be
aware of the variability in imaging features of haeman-
giopericytomas, although the underlying reason for these
differences in imaging features is uncertain. We speculate
that this variability in imaging features reflects the
heterogeneity of histological or biological features of
haemangiopericytomas and needs to be further explored.
FDG-PET may be helpful in differentiating necrotic
tumours from hypoenhancing but viable tumours, both
of which are hypoenhancing on CT but demonstrate
different metabolic activities on PET, and thus poten-
tially guide treatment decisions. However, further
evaluation of 18F-FDG-PET-CT use and other molecular
imaging techniques, and correlation of the imaging
findings with histological features, would be helpful.
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